Platelet Rich Plasma Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
Platelet Rich Plasma Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
The global platelet rich plasma market is expected to grow at a CAGR of around 9.2% during 2025-2034. This report on global platelet rich plasma market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global platelet rich plasma market by segmenting the market based on origin, type, application, end user and region. Also, detailed profiles of companies operating in the platelet rich plasma market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
• Growing Sports Injuries • Increasing Number of Cosmetic Surgeries
Market Challenges
• High Cost for Products
Historical & Forecast Period
Base Year: 2024 Historical Period: 2020-2024 Forecast Period: 2025-2034
Market by Origin
• Autologous • Allogeneic • Homologous
Market by Type
• Pure PRP • Leukocyte-rich PRP • Leukocyte-rich Fibrin • Other Types
Market by Application
• Orthopedics • Cosmetic Surgery and Dermatology • Neurology • Cardiology • Ophthalmology • Other Applications
Market by End User
• Hospitals and Clinics • Research Institutes Market by Region
• Europe Germany United Kingdom France Italy Spain Russia Netherlands Rest of Europe • North America United States Canada • Asia Pacific China Japan India South Korea Australia Indonesia Rest of Asia Pacific • Latin America Mexico Brazil Argentina Rest of Latin America • Middle East & Africa Saudi Arabia Turkey Iran United Arab Emirates Rest of Middle East & Africa
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Platelet Rich Plasma Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Platelet Rich Plasma Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Platelet Rich Plasma Market by Origin
5.1. Introduction
5.2. Autologous
5.3. Allogeneic
5.4. Homologous
6. Global Platelet Rich Plasma Market by Type
6.1. Introduction
6.2. Pure PRP
6.3. Leukocyte-rich PRP
6.4. Leukocyte-rich Fibrin
6.5. Other Types
7. Global Platelet Rich Plasma Market by Application
7.1. Introduction
7.2. Orthopedics
7.3. Cosmetic Surgery and Dermatology
7.4. Neurology
7.5. Cardiology
7.6. Ophthalmology
7.7. Other Applications
8. Global Platelet Rich Plasma Market by End User
8.1. Introduction
8.2. Hospitals and Clinics
8.3. Research Institutes
9. Global Platelet Rich Plasma Market by Region
9.1. Introduction
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Russia
9.2.7. Netherlands
9.2.8. Rest of the Europe
9.3. North America
9.3.1. United States
9.3.2. Canada
9.4. Asia Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. South Korea
9.4.5. Australia
9.4.6. Indonesia
9.4.7. Rest of the Asia Pacific
9.5. Latin America
9.5.1. Mexico
9.5.2. Brazil
9.5.3. Argentina
9.5.4. Rest of Latin America
9.6. Middle East & Africa
9.6.1. Saudi Arabia
9.6.2. Turkey
9.6.3. Iran
9.6.4. United Arab Emirates
9.6.5. Rest of Middle East & Africa
10. SWOT Analysis
11. Porter’s Five Forces
12. Market Value Chain Analysis
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Company Profiles
13.2.1. Arthrex Inc.
13.2.2. DePuy Synthes
13.2.3. Dr. PRP USA LLC
13.2.4. EmCyte Corporation
13.2.5. Glofinn Oy
13.2.6. Harvest Technologies Corporation
13.2.7. Isto Biologics
13.2.8. Johnson and Johnson Ltd.
13.2.9. Stryker Corporation
13.2.10. T-Biotechnology
13.2.11. Terumo BCT Inc.
13.2.12. Vertical Spine LLC
13.2.13. Zimmer Biomet
List of Figures
Figure 1: Global Platelet Rich Plasma Market (in US$ Million), 2020-2024
Figure 2: Global Platelet Rich Plasma Market by Origin, 2024
Figure 3: Global Platelet Rich Plasma Market by Type, 2024
Figure 4: Global Platelet Rich Plasma Market by Application, 2024
Figure 5: Global Platelet Rich Plasma Market by End User, 2024
Figure 6: Global Platelet Rich Plasma Market by Region, 2024
Figure 7: Global Platelet Rich Plasma Market (in US$ Million), 2025-2034
Figure 8: Global Platelet Rich Plasma Market by Origin (in %), 2024 & 2034
Figure 9: Global Autologous Platelet Rich Plasma Market (in US$ Million), 2020-2024
Figure 10: Global Autologous Platelet Rich Plasma Market (in US$ Million), 2025-2034
Figure 11: Global Allogeneic Platelet Rich Plasma Market (in US$ Million), 2020-2024
Figure 12: Global Allogeneic Platelet Rich Plasma Market (in US$ Million), 2025-2034
Figure 13: Global Homologous Platelet Rich Plasma Market (in US$ Million), 2020-2024
Figure 14: Global Homologous Platelet Rich Plasma Market (in US$ Million), 2025-2034
Figure 15: Global Platelet Rich Plasma Market by Type (in %), 2024 & 2034
Figure 16: Global Pure PRP Platelet Rich Plasma Market (in US$ Million), 2020-2024
Figure 17: Global Pure PRP Platelet Rich Plasma Market (in US$ Million), 2025-2034
Figure 18: Global Leukocyte-rich PRP Platelet Rich Plasma Market (in US$ Million), 2020-2024
Figure 19: Global Leukocyte-rich PRP Platelet Rich Plasma Market (in US$ Million), 2025-2034
Figure 20: Global Leukocyte-rich Fibrin Platelet Rich Plasma Market (in US$ Million), 2020-2024
Figure 21: Global Leukocyte-rich Fibrin Platelet Rich Plasma Market (in US$ Million), 2025-2034
Figure 22: Global Other Types Filtration Market (in US$ Million), 2020-2024
Figure 23: Global Other Types Filtration Market (in US$ Million), 2020-2034
Figure 24: Global Platelet Rich Plasma Market by Application (in %), 2024 & 2034
Figure 25: Global Orthopedics Platelet Rich Plasma Market (in US$ Million), 2020-2024
Figure 26: Global Orthopedics Platelet Rich Plasma Market (in US$ Million), 2025-2034
Figure 27: Global Cosmetic Surgery and Dermatology Platelet Rich Plasma Market (in US$ Million), 2020-2024
Figure 28: Global Cosmetic Surgery and Dermatology Platelet Rich Plasma Market (in US$ Million), 2025-2034
Figure 29: Global Neurology Platelet Rich Plasma Market (in US$ Million), 2020-2024
Figure 30: Global Neurology Platelet Rich Plasma Market (in US$ Million), 2025-2034
Figure 31: Global Cardiology Filtration Market (in US$ Million), 2020-2024
Figure 32: Global Cardiology Filtration Market (in US$ Million), 2025-2034
Figure 33: Global Ophthalmology Filtration Market (in US$ Million), 2020-2024
Figure 34: Global Ophthalmology Filtration Market (in US$ Million), 2025-2034
Figure 35: Global Other Applications Platelet Rich Plasma Market (in US$ Million), 2020-2024
Figure 36: Global Other Applications Platelet Rich Plasma Market (in US$ Million), 2025-2034
Figure 37: Global Platelet Rich Plasma Market by End User (in %), 2024 & 2034
Figure 38: Global Hospitals and Clinics Platelet Rich Plasma Market (in US$ Million), 2020-2024
Figure 39: Global Hospitals and Clinics Platelet Rich Plasma Market (in US$ Million), 2025-2034
Figure 40: Global Research Institutes Platelet Rich Plasma Market (in US$ Million), 2020-2024
Figure 41: Global Research Institutes Platelet Rich Plasma Market (in US$ Million), 2025-2034
Figure 42: Global Platelet Rich Plasma Market by Region (in %), 2024 & 2034
Figure 43: Europe Platelet Rich Plasma Market (in US$ Million), 2020-2024
Figure 44: Europe Platelet Rich Plasma Market (in US$ Million), 2025-2034
Figure 45: Europe Platelet Rich Plasma Market by Country (in %), 2024 & 2034